Alfa Wassermann Separation Technologies (AWST), a division of Alfa Wassermann Inc., is dedicated to advancing the bioprocess and pharmaceutical industries through specialized expertise in continuous flow ultra-centrifugation (UCF) separation applications where consistency and scalable purifications are essential. While widely known for our supporting human biotherapeutics, AWST also plays a vital role in the development and production of animal health vaccines by offering high-performance, yet cost effective, separation solutions that meet the rigorous demands of veterinary biologics manufacturing. In addition to our family of linear scalable cGMP ultracentrifuges, a fully automated fluid handling system can now be part of your bio-process and fluid handling solutions. AWST systems are designed, manufactured, serviced, and supported to the highest level of quality resulting in:
- Maximized product yield
- Unsurpassed product quality
- Cost savings
The bioprocess industry has relied on AWST's experience in manufacturing continuous flow cGMP ultracentrifuges for the development and production of vaccines and other bio-products for over 60 years. AWST cGMP ultracentrifuges efficiently and reliably:
- Separate and purify viruses, virus like particles and viral vectors.
- Provide unsurpassed separation of full and empty AAV capsids.
- Deliver unsurpassed product yield in a linear scalable process.
